v3.25.1
ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Narrative) (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Feb. 06, 2025
USD ($)
$ / shares
shares
Sep. 01, 2023
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
item
Jun. 30, 2024
USD ($)
item
Mar. 31, 2024
USD ($)
item
Dec. 31, 2024
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
Business Acquisition [Line Items]                
Research and development     $ 33,062     $ 57,268    
Contingent consideration liability     118,055       $ 123,235  
Goodwill     1,432,964       1,432,387 $ 1,434,540
Patents amount     1,053,144       $ 1,046,227  
Fibriant B.V. [Member]                
Business Acquisition [Line Items]                
Research and development           12,600    
Contingent consideration payment           12,000    
Asset Acquisition, Consideration Transferred           12,000    
Medical Device Technology [Member]                
Business Acquisition [Line Items]                
Patents amount     $ 5,000          
Percent of license fee     1.00%          
Useful Life     10 years 1 month 6 days          
Achievement Of Certain Performance Obligation [Member] | Fibriant B.V. [Member]                
Business Acquisition [Line Items]                
Additional contingent consideration           $ 10,000    
Series of Individually Immaterial Business Acquisitions [Member]                
Business Acquisition [Line Items]                
Number of acquisitions | item       1 1 1    
Weighted average amortization period           10 years    
Goodwill           $ 17,900    
Purchase price       $ 100 $ 100 500    
Contingent consideration liability       $ 1,600 $ 1,900      
Contingent payments, performance period       5 years 5 years      
Goodwill       $ 1,700 $ 2,000      
Contingent consideration payment           19,100    
Fair value adjustments to inventory           $ 1,800    
NuVasive [Member]                
Business Acquisition [Line Items]                
Identifiable Assets   $ 1,394,000            
Business combination, consideration transferred $ 250,000 2,604,000            
Goodwill   $ 1,210,000            
Common stock, par value | $ / shares $ 0.001              
Conversion ratio of common stock | shares 5.85              
Common Class A [Member]                
Business Acquisition [Line Items]                
Common stock, par value | $ / shares     $ 0.001       $ 0.001  
Conversion ratio of common stock | shares     1          
Common Class A [Member] | NuVasive [Member]                
Business Acquisition [Line Items]                
Common stock, par value | $ / shares   $ 0.001            
Conversion ratio of common stock | shares   0.75